| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam [M. K., M. d. H., P. B.]; Department of Pathology, Free University Hospital, 1081 HV Amsterdam [G. L. S., R. J. S.]; Department of Pediatric Gastroenterology and Laboratory for Metabolic Diseases, Wilhelmina Children's Hospital, 3501 CA Utrecht [M. J. T. v. E., J. A. J.]; and Department of Neurology, Academic Medical Center, 1105 AZ Amsterdam [F. B.], the Netherlands
By screening databases of human expressed sequence tags, we have identified three new homologues of MRP1, the gene encoding the multidrug resistance-associated protein, and cMOAT (or MRP2), the canalicular multispecific organic anion transporter gene. We call these new genes MRP3, MRP4, and MRP5. MRP3, like cMOAT, is mainly expressed in the liver. MRP4 is expressed only at very low levels in a few tissues, and MRP5, like MRP1, is expressed in almost every tissue tested. To assess a possible role of these new MRP homologues in multidrug or cisplatin resistance, a large set of resistant cell lines was examined for the (over)expression of MRP1, cMOAT, MRP3, MRP4, and MRP5. We find that even in cells selected for a low level of resistance, several MRP-related genes can be up-regulated simultaneously. However, MRP4 is not overexpressed in any of the cell lines we analyzed; MRP3 and MRP5 are only overexpressed in a few cell lines, and the RNA levels do not seem to correlate with resistance to either doxorubicin or cisplatin. cMOAT is substantially overexpressed in several cell lines, and cMOAT RNA levels correlate with cisplatin but not doxorubicin resistance in a subset of resistant cell lines. Our results emphasize the need for gene-specific blocks in gene expression to define which transporter contributes to resistance in each resistant cell line.
1 This work was supported by a grant from the Dutch Cancer Society (to F. B. and P. B.).
2 To whom requests for reprints should be addressed. Phone: 31-20-5122880; Fax: 31-20-6691383.
Received 1/27/97. Accepted 6/11/97.
This article has been cited by other articles:
![]() |
Md. T. Hoque and S. P.C. Cole Down-regulation of Na+/H+ Exchanger Regulatory Factor 1 Increases Expression and Function of Multidrug Resistance Protein 4 Cancer Res., June 15, 2008; 68(12): 4802 - 4809. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, Y. Tang, M.-T. Wang, S. Zeng, and D. Nie Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer Cancer Res., November 1, 2007; 67(21): 10361 - 10367. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Letourneau, A. J. Slot, R. G. Deeley, and S. P. C. Cole Mutational Analysis of a Highly Conserved Proline Residue in MRP1, MRP2, and MRP3 Reveals a Partially Conserved Function Drug Metab. Dispos., August 1, 2007; 35(8): 1372 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Choi, J. W. Yang, S. H. Roh, C. Y. Han, and K. W. Kang Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells Endocr. Relat. Cancer, June 1, 2007; 14(2): 293 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imaoka, H. Kusuhara, M. Adachi, J. D. Schuetz, K. Takeuchi, and Y. Sugiyama Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir Mol. Pharmacol., February 1, 2007; 71(2): 619 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Surowiak, V. Materna, I. Kaplenko, M. Spaczynski, B. Dolinska-Krajewska, E. Gebarowska, M. Dietel, M. Zabel, and H. Lage ABCC2 (MRP2, cMOAT) Can Be Localized in the Nuclear Membrane of Ovarian Carcinomas and Correlates with Resistance to Cisplatin and Clinical Outcome Clin. Cancer Res., December 1, 2006; 12(23): 7149 - 7158. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Bachmeier, W. J. Trickler, and D. W. Miller COMPARISON OF DRUG EFFLUX TRANSPORT KINETICS IN VARIOUS BLOOD-BRAIN BARRIER MODELS Drug Metab. Dispos., June 1, 2006; 34(6): 998 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dallas, D. S. Miller, and R. Bendayan Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol. Rev., June 1, 2006; 58(2): 140 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Couture, J. A. Nash, and J. Turgeon The ATP-Binding Cassette Transporters and Their Implication in Drug Disposition: A Special Look at the Heart. Pharmacol. Rev., June 1, 2006; 58(2): 244 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamaguchi, Y. L. Zhao, M. Nadai, H. Yoshizumi, X. Cen, S. Torita, K. Takagi, K. Takagi, and T. Hasegawa Involvement of the Drug Transporters P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 in Telithromycin Transport Antimicrob. Agents Chemother., January 1, 2006; 50(1): 80 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Maher, A. L. Slitt, N. J. Cherrington, X. Cheng, and C. D. Klaassen TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE Drug Metab. Dispos., July 1, 2005; 33(7): 947 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pichler, N. Zelcer, J. L. Prior, A. J. Kuil, and D. Piwnica-Worms In vivo RNA Interference-Mediated Ablation of MDR1 P-Glycoprotein Clin. Cancer Res., June 15, 2005; 11(12): 4487 - 4494. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pratt, R. L. Shepard, R. A. Kandasamy, P. A. Johnston, W. Perry III, and A. H. Dantzig The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites Mol. Cancer Ther., May 1, 2005; 4(5): 855 - 863. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakatsu, Y. Yoshida, K. Yamazaki, T. Nakamura, S. Dan, Y. Fukui, and T. Yamori Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays Mol. Cancer Ther., March 1, 2005; 4(3): 399 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Riganti, E. Miraglia, D. Viarisio, C. Costamagna, G. Pescarmona, D. Ghigo, and A. Bosia Nitric Oxide Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells by Inhibiting the Drug Efflux Cancer Res., January 15, 2005; 65(2): 516 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jedlitschky, K. Tirschmann, L. E. Lubenow, H. K. Nieuwenhuis, J. W. N. Akkerman, A. Greinacher, and H. K. Kroemer The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage Blood, December 1, 2004; 104(12): 3603 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. E. Sauna, K. Nandigama, and S. V. Ambudkar Multidrug Resistance Protein 4 (ABCC4)-mediated ATP Hydrolysis: EFFECT OF TRANSPORT SUBSTRATES AND CHARACTERIZATION OF THE POST-HYDROLYSIS TRANSITION STATE J. Biol. Chem., November 19, 2004; 279(47): 48855 - 48864. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. D. Schuetz, W. F. Elmquist, and D. W. Miller Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Inoue, T. Otsuki, A. Hirasawa, I. Imoto, Y. Matsuo, S. Shimizu, M. Taniwaki, and J. Inazawa Overexpression of PDZK1 within the 1q12-q22 Amplicon Is Likely To Be Associated with Drug-Resistance Phenotype in Multiple Myeloma Am. J. Pathol., July 1, 2004; 165(1): 71 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sugie, E. Asakura, Y. L. Zhao, S. Torita, M. Nadai, K. Baba, K. Kitaichi, K. Takagi, K. Takagi, and T. Hasegawa Possible Involvement of the Drug Transporters P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 in Disposition of Azithromycin Antimicrob. Agents Chemother., March 1, 2004; 48(3): 809 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gennuso, C. Fernetti, C. Tirolo, N. Testa, F. L'Episcopo, S. Caniglia, M. C. Morale, J. D. Ostrow, L. Pascolo, C. Tiribelli, et al. Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1) PNAS, February 24, 2004; 101(8): 2470 - 2475. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Smitherman, A. J. Townsend, T. E. Kute, and C. S. Morrow Role of Multidrug Resistance Protein 2 (MRP2, ABCC2) in Alkylating Agent Detoxification: MRP2 Potentiates Glutathione S-Transferase A1-1-Mediated Resistance to Chlorambucil Cytotoxicity J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 260 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dazert, K. Meissner, S. Vogelgesang, B. Heydrich, L. Eckel, M. Bohm, R. Warzok, R. Kerb, U. Brinkmann, E. Schaeffeler, et al. Expression and Localization of the Multidrug Resistance Protein 5 (MRP5/ABCC5), a Cellular Export Pump for Cyclic Nucleotides, in Human Heart Am. J. Pathol., October 1, 2003; 163(4): 1567 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Leonard, T. Fojo, and S. E. Bates The Role of ABC Transporters in Clinical Practice Oncologist, October 1, 2003; 8(5): 411 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Reid, P. Wielinga, N. Zelcer, I. van der Heijden, A. Kuil, M. de Haas, J. Wijnholds, and P. Borst The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs PNAS, August 5, 2003; 100(16): 9244 - 9249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Ros, T A D Roskams, M Geuken, R Havinga, P L Splinter, B E Petersen, N F LaRusso, D M van der Kolk, F Kuipers, K N Faber, et al. ATP binding cassette transporter gene expression in rat liver progenitor cells Gut, July 1, 2003; 52(7): 1060 - 1067. [Abstract] [Full Text] |
||||
![]() |
A. C. Lockhart, R. G. Tirona, and R. B. Kim Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy Mol. Cancer Ther., July 1, 2003; 2(7): 685 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mayer, F. Honecker, L. H. J. Looijenga, and C. Bokemeyer Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors Ann. Onc., June 1, 2003; 14(6): 825 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
R O. Elferink Cholestasis Gut, May 1, 2003; 52(90002): ii42 - 48. [Abstract] [Full Text] |
||||
![]() |
I.-S. Song, Y.-M. Lee, S.-J. Chung, and C.-K. Shim Multiple Alterations of Canalicular Membrane Transport Activities in Rats with CCl4-induced Hepatic Injury Drug Metab. Dispos., April 1, 2003; 31(4): 482 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kocher, R. Pal, M. Roberts, C. Cirovic, and A. Gilchrist Targeted Disruption of the PDZK1 Gene by Homologous Recombination Mol. Cell. Biol., February 15, 2003; 23(4): 1175 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Oleschuk, R. G. Deeley, and S. P. C. Cole Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3 Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G280 - G289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Lamba, M. Adachi, D. Sun, J. Tammur, E. G. Schuetz, R. Allikmets, and J. D. Schuetz Nonsense mediated decay downregulates conserved alternatively spliced ABCC4 transcripts bearing nonsense codons Hum. Mol. Genet., January 15, 2003; 12(2): 99 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu and M. A. Villalona-Calero Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity Ann. Onc., December 1, 2002; 13(12): 1841 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Wielinga, G. Reid, E. E. Challa, I. van der Heijden, L. van Deemter, M. de Haas, C. Mol, A. J. Kuil, E. Groeneveld, J. D. Schuetz, et al. Thiopurine Metabolism and Identification of the Thiopurine Metabolites Transported by MRP4 and MRP5 Overexpressed in Human Embryonic Kidney Cells Mol. Pharmacol., December 1, 2002; 62(6): 1321 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohishi, Y. Oda, T. Uchiumi, H. Kobayashi, T. Hirakawa, S. Miyamoto, N. Kinukawa, H. Nakano, M. Kuwano, and M. Tsuneyoshi ATP-binding Cassette Superfamily Transporter Gene Expression in Human Primary Ovarian Carcinoma Clin. Cancer Res., December 1, 2002; 8(12): 3767 - 3775. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burg, P. Wielinga, N. Zelcer, T. Saeki, G. J. Mulder, and P. Borst Inhibition of the Multidrug Resistance Protein 1 (MRP1) by Peptidomimetic Glutathione-Conjugate Analogs Mol. Pharmacol., November 1, 2002; 62(5): 1160 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Qian, C. E. Grant, C. J. Westlake, D.-W. Zhang, P. A. Lander, R. L. Shepard, A. H. Dantzig, S. P. C. Cole, and R. G. Deeley Photolabeling of Human and Murine Multidrug Resistance Protein 1 with the High Affinity Inhibitor [125I]LY475776 and Azidophenacyl-[35S]Glutathione J. Biol. Chem., September 13, 2002; 277(38): 35225 - 35231. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, B. Stieger, P. J. Meier, and M. Vore Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G757 - G766. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yan and E. M. Taylor Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters Drug Metab. Dispos., May 1, 2002; 30(5): 513 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Audus, M. J. Soares, and J. S. Hunt Characteristics of the Fetal/Maternal Interface with Potential Usefulness in the Development of Future Immunological and Pharmacological Strategies J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 402 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
G L Scheffer, A C L M Pijnenborg, E F Smit, M Muller, D S Postma, W Timens, P van der Valk, E G E de Vries, and R J Scheper Multidrug resistance related molecules in human and murine lung J. Clin. Pathol., May 1, 2002; 55(5): 332 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanaka, Y. Kobayashi, E. C. Gabazza, K. Higuchi, T. Kamisako, M. Kuroda, K. Takeuchi, M. Iwasa, M. Kaito, and Y. Adachi Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G656 - G662. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rost, S. Mahner, Y. Sugiyama, and W. Stremmel Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G720 - G726. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. van Aubel, P. H. E. Smeets, J. G. P. Peters, R. J. M. Bindels, and F. G. M. Russel The MRP4/ABCC4 Gene Encodes a Novel Apical Organic Anion Transporter in Human Kidney Proximal Tubules: Putative Efflux Pump for Urinary cAMP and cGMP J. Am. Soc. Nephrol., March 1, 2002; 13(3): 595 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Williams and M. J. Iatropoulos Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity Toxicol Pathol, January 1, 2002; 30(1): 41 - 53. [Abstract] [PDF] |
||||
![]() |
A. Inokuchi, E. Hinoshita, Y. Iwamoto, K. Kohno, M. Kuwano, and T. Uchiumi Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes. A TRANSCRIPTIONAL CONTROL OF A PLAUSIBLE BILE ACID TRANSPORTER J. Biol. Chem., December 7, 2001; 276(50): 46822 - 46829. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zelcer, T. Saeki, G. Reid, J. H. Beijnen, and P. Borst Characterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3) J. Biol. Chem., November 30, 2001; 276(49): 46400 - 46407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, H. Melhus, P. Garberg, B. Sjostrom, B. Lundgren, and P. Artursson Correlation of Gene Expression of Ten Drug Efflux Proteins of the ATP-Binding Cassette Transporter Family in Normal Human Jejunum and in Human Intestinal Epithelial Caco-2 Cell Monolayers J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 164 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, H. Suzuki, and Y. Sugiyama Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G1034 - G1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zeng, Z.-S. Chen, M. G. Belinsky, P. A. Rea, and G. D. Kruh Transport of Methotrexate (MTX) and Folates by Multidrug Resistance Protein (MRP) 3 and MRP1: Effect of Polyglutamylation on MTX Transport Cancer Res., October 1, 2001; 61(19): 7225 - 7232. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Z. Khokhar, Y. She, V. W. Rusch, and F. M. Sirotnak Experimental Therapeutics with a New 10-Deazaaminopterin in Human Mesothelioma: Further Improving Efficacy through Structural Design, Pharmacologic Modulation at the Level of MRP ATPases, and Combined Therapy with Platinums Clin. Cancer Res., October 1, 2001; 7(10): 3199 - 3205. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamada, K. Kawano, M. Koga, T. Matsumoto, and K. Itoh Multidrug Resistance-associated Protein 3 Is a Tumor Rejection Antigen Recognized by HLA-A2402-restricted Cytotoxic T Lymphocytes Cancer Res., September 1, 2001; 61(17): 6459 - 6466. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Young, B. G. Campling, S. P. C. Cole, R. G. Deeley, and J. H. Gerlach Multidrug Resistance Proteins MRP3, MRP1, and MRP2 in Lung Cancer: Correlation of Protein Levels with Drug Response and Messenger RNA Levels Clin. Cancer Res., June 1, 2001; 7(6): 1798 - 1804. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, H. Suzuki, and Y. Sugiyama Charged Amino Acids in the Transmembrane Domains Are Involved in the Determination of the Substrate Specificity of Rat Mrp2 Mol. Pharmacol., April 16, 2001; 59(5): 1077 - 1085. [Abstract] [Full Text] |
||||
![]() |
M. Maliepaard, G. L. Scheffer, I. F. Faneyte, M. A. van Gastelen, A. C. L. M. Pijnenborg, A. H. Schinkel, M. J. van de Vijver, R. J. Scheper, and J. H. M. Schellens Subcellular Localization and Distribution of the Breast Cancer Resistance Protein Transporter in Normal Human Tissues Cancer Res., April 1, 2001; 61(8): 3458 - 3464. [Abstract] [Full Text] |
||||
![]() |
K. Lee, A. J. P. Klein-Szanto, and G. D. Kruh Analysis of the MRP4 Drug Resistance Profile in Transfected NIH3T3 Cells J Natl Cancer Inst, December 6, 2000; 92(23): 1934 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
|